Ponz, InesNuche, JorgeSánchez Sánchez, VioletaSánchez González, JavierBlázquez Bermejo, ZorbaCaravaca Pérez, PedroGarcía Cosio Carmena, Maria DoloresJuan Baguda, Javier S. DeRodríguez Chaverri, Adriana RodríguezSarnago Cebada, FernandoArribas Ynsaurriaga, FernandoIbañez, BorjaDelgado Jiménez, Juan Francisco2023-06-172023-06-172021-01-05Ponz, I., Nuche, J., Sánchez Sánchez, V. et al. «Non-Invasive Assessment of Pulmonary Vasculopathy». Hearts, vol. 2, n.o 1, enero de 2021, pp. 5-14. DOI.org (Crossref), https://doi.org/10.3390/hearts2010002.2673-384610.3390/hearts2010002https://hdl.handle.net/20.500.14352/7057Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic data.engAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/journal articlehttps://doi.org/10.3390/hearts2010002https://www.mdpi.com/2673-3846/2/1/2/htmopen accessHeart failurePulmonary hypertensionCardiovascular magnetic resonanceRight heart catheterizationCardiologíaNeumología3205.01 Cardiología3205.08 Enfermedades Pulmonares